S 2076 117th Congress Senate Health Administrative law and regulatory procedures Advisory bodies Appropriations Congressional oversight Department of Health and Human Services Drug safety, medical device, and laboratory regulation Drug therapy Executive agency funding and structure Government information and archives Government studies and investigations Health programs administration and funding Indian social and development programs Infectious and parasitic diseases Manufacturing Medicaid Medicare Military medicine Minority health Prescription drugs

PASTEUR Act of 2021

Introduced: June 16, 2021 Introduced by: Bennet, Michael F. Democratic · Colorado See on congress.gov

Everywhere this bill has been 2 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Jun 16, 2021

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Jun 16, 2021

Introduced in Senate

Plain-English summary Congressional Research Service

The Pioneering Antimicrobial Subscriptions To End Up surging Resistance Act of 2021 or the PASTEUR Act of 2021

This bill authorizes the Department of Health and Human Services (HHS) to enter into subscription contracts for critical-need antimicrobial drugs, provides $11 billion in appropriations for activities under the bill, and contains other related provisions.

A manufacturer of a Food and Drug Administration-approved antimicrobial drug may apply to HHS to have the drug designated as a critical-need antimicrobial, and HHS may enter into a subscription contract for such a critical-need antimicrobial. The bill imposes certain requirements related to such contracts, including a mechanism to lower payments under the contract in certain instances to limit the manufacturer's revenue from the drug.

Furthermore, HHS and the Centers for Disease Control and Prevention (CDC) shall award grants to support efforts to encourage the appropriate use of antimicrobial drugs and efforts to combat antimicrobial resistance. The CDC shall also track and assess data relating to antibacterial resistance and human antibiotic use and make such data publicly available.

HHS shall also establish a Committee on Critical Need Antimicrobials. The committee shall develop a list of prioritized infections for which new antimicrobial drug development is needed, among other duties.

Within six years of the bill's enactment, the Government Accountability Office shall report to Congress a study on the bill's effectiveness in developing priority antimicrobial drugs.

What's happening now June 16, 2021

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Committees of jurisdiction 1